13Apr
12Apr
A single celled replacement for fishmeal?
Large scale production of a single cell organism could reduce the need to use wild-caught fish and agricultural crops as the key protein ingredients in aquaculture feeds, according to a new study published in PEERJ today. The study, entitled A Transdisciplinary Approach To The Initial Validation Of A Single Cell Protein As An Alternative Protein Source For Use In Aquafeeds, is the result of a collaboration between researchers at a Massachusetts-based biotechnology company – KnipBio, Inc – the New England Aquarium,...
12Apr
7-year-old gets eSight glasses to help vision
Payton Crum, a 7-year-old first grader, got her best surprise yet Tuesday -- hi-tech glasses that will help improve her vision. As a result of the surprise, she was able to clearly Easter eggs for the first time. "I love how you can make it farther, bigger and colorful and stuff," Crum said. Crum filled her pink Easter basket. As her mother holds her hand, the 7-year-old can now control her vision. "This thing right here, it zooms in and zooms out," she said. They're...
10Apr
Early Stage by John Valentine/3Derm
Liz Asai, Co-Founder and CEO of Boston-based digital health startup 3Derm, joins Early Stage on the pod for Episode 10. Listen now >>
08Apr
Airey seeks high tech vision aid
At a demonstration at the Carroll Center for the Blind in Newton, Andrew tested a pair of eSight glasses that showed promise. “It was pretty amazing,” he said. “At the time, they were very heavy, but now there is a smaller, sleeker model.” Read more >>
07Apr
Regroup Presents Live Webinar to Highlight Critical Aspects of Cyber Security for 2017
Regroup Mass Notification, the award-winning leader in emergency and day-to-day mass communication technology, will be presenting an informative webinar to cover the most important aspects of cyber security for organizations. Read more >>
05Apr
Corbus Pharma outlines U.S. approval path for lead drug
The U.S. Food and Drug Administration needs Corbus Pharmaceuticals to show positive data from only one late-stage study on its experimental treatment for scleroderma to support a marketing application, the company said. Read more >>
05Apr
Siamab Therapeutics Presents New Preclinical Data for Its Novel Anti-STn Antibodies, Antibody-Drug Conjugates, and Anti-STn Bispecific Antibodies at the AACR Annual Meeting 2017
Siamab Therapeutics, Inc., a biopharmaceutical company developing novel cancer immunotherapies, today announced the presentation of two posters featuring new preclinical data for its novel anti-Sialyl-Tn (STn) antibodies, antibody-drug conjugates (ADCs), and anti-STn, anti-CD3 bispecific antibodies at the American Association for Cancer Research (AACR) Annual Meeting 2017, being held April 1-5, 2017 in Washington, D.C. Read more >>
04Apr
Intellectual Property and Patent Law
The following post is from Antonette Ho, Group Operations Manager at Boston Harbor Angels. David Powsner Earlier in March, the Boston Harbor Angels held an Intellectual Property (IP) and Patent Law Workshop at Nutter, a sponsor of Boston Harbor Angels. David Powsner, a Partner in the Intellectual Property Department, and a member of Boston Harbor Angels, facilitated the session. Powsner shared the different types of intellectual property, questions to ask when it comes to IP and resources for further investigation. Intellectual property is...
03Apr